Tympanic Membrane Perforation After Intratympanic Steroid Injection: A Systematic Review and Meta-analysis
- PMID: 34058895
- DOI: 10.1177/01945998211012300
Tympanic Membrane Perforation After Intratympanic Steroid Injection: A Systematic Review and Meta-analysis
Abstract
Objective: We investigated the incidence of tympanic membrane (TM) perforations induced after intratympanic steroid injection (ITSI) in patients with sudden sensorineural hearing loss (SSNHL) through a systematic review and meta-analysis.
Data sources: PubMed, Embase, and MEDLINE.
Review methods: Primary database searches were performed, and 1901 records were identified. After removal of 1802 articles through abstract screening, the remaining 99 full-text journals were assessed for eligibility to be included in the study. Fifty-eight studies that used either ventilation tubing (VT) or tympanocentesis (TC) for ITSI were selected for analysis. The subjects were divided into VT and TC groups. The rate of TM perforation after ITSI in 2 groups, sites of ITSI, needle gauge, and influence on residual hearing were investigated.
Results: The cohorts comprised patients who underwent VT (n = 257, 9.6%) and TC (n = 2415, 90.4%). The proportion of TM perforation after ITSI in each group was 0.073 (95% CI, 0.0469-0.1113) and 0.010 (95% CI, 0.0045-0.0215), respectively, which suggested that the VT group showed a significantly higher TM perforation rate than the TC group (P < .001). In the subgroup analyses, there was no significant difference in the odds ratio for the rate of TM perforation according to the injection site and needle gauge for TC. The proportion of surgical repair showed no significant difference between the 2 groups.
Conclusion: ITSI via VT may have a significantly higher risk of TM perforation than ITSI via TC, although those are relatively small overall. ITSI should be performed in the direction to minimize possible adverse effects.
Keywords: intratympanic steroid injection; meta-analysis; sudden sensorineural hearing loss; tympanic membrane perforation.
Comment in
-
Letter to the Editor Regarding "Tympanic Membrane Perforation After Intratympanic Steroid Injection: A Systematic Review and Meta-analysis" by Kim et al.Otolaryngol Head Neck Surg. 2022 Aug;167(2):410. doi: 10.1177/01945998211043850. Otolaryngol Head Neck Surg. 2022. PMID: 35913807 No abstract available.
Similar articles
-
Complications and prognosis associated with intra-tympanic steroid injection to treat sudden sensorineural hearing impairment.Am J Otolaryngol. 2022 Jan-Feb;43(1):103221. doi: 10.1016/j.amjoto.2021.103221. Epub 2021 Sep 10. Am J Otolaryngol. 2022. PMID: 34536925
-
Retrospective study of risk factors for tympanic membrane perforation in the early period after intratympanic steroid injection.Auris Nasus Larynx. 2023 Oct;50(5):714-719. doi: 10.1016/j.anl.2023.01.012. Epub 2023 Feb 10. Auris Nasus Larynx. 2023. PMID: 36775771
-
Residual Perforation Risk Assessment of Intratympanic Steroids via Tympanostomy Tube Versus Transtympanic Injections.Laryngoscope. 2021 Sep;131(9):E2583-E2591. doi: 10.1002/lary.29609. Epub 2021 May 18. Laryngoscope. 2021. PMID: 34002883
-
Intratympanic vs Systemic Corticosteroids in First-line Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):421-428. doi: 10.1001/jamaoto.2020.0047. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32163109 Free PMC article.
-
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15. Laryngoscope. 2007. PMID: 17202923 Review.
Cited by
-
Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis.Clin Exp Otorhinolaryngol. 2022 Feb;15(1):91-99. doi: 10.21053/ceo.2021.01459. Epub 2022 Feb 12. Clin Exp Otorhinolaryngol. 2022. PMID: 35144363 Free PMC article.
-
Therapeutic effectiveness of intratympanic and retroauricular methylprednisolone sodium succinate for refractory sudden sensorineural hearing loss in diabetic patients.World J Diabetes. 2025 May 15;16(5):99576. doi: 10.4239/wjd.v16.i5.99576. World J Diabetes. 2025. PMID: 40487598 Free PMC article.
-
The efficacy of methylprednisolone acetate nanogel in treating patients with sudden sensorineural hearing loss.Sci Rep. 2025 Apr 10;15(1):12342. doi: 10.1038/s41598-025-97145-6. Sci Rep. 2025. PMID: 40211027 Free PMC article. Clinical Trial.
-
From mechanism to applications: Advanced microneedles for clinical medicine.Bioact Mater. 2025 May 5;51:1-45. doi: 10.1016/j.bioactmat.2025.04.025. eCollection 2025 Sep. Bioact Mater. 2025. PMID: 40463395 Free PMC article. Review.
-
Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss.Front Pharmacol. 2024 Jan 16;15:1294657. doi: 10.3389/fphar.2024.1294657. eCollection 2024. Front Pharmacol. 2024. PMID: 38292943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources